https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Tenapanor in Hyperphosphatemia Is Effective but Has Cost, Market Barriers

Tenapanor in Hyperphosphatemia Is Effective but Has Cost, Market Barriers

Tenapanor offers a new approach to managing hyperphosphatemia in dialysis patients, balancing effectiveness with pill burden and cost considerations.

administrator

Related Articles